Tagged as: Millennium

Genentech Files Lawsuits Against Biogen and Millennium for Past Royalties on the Cabilly Patents

This week, Genentech filed separate lawsuits against Biogen and Millennium, alleging breach of a license agreement to the Cabilly patents (U.S. Patent No. 6,331,415 and 7,923,221).  The patents are generally directed to processes for producing an antibody or an antibody fragment by transforming a host cell with a first and…

Read More